google-site-verification=yzG5X3wSoDwFeTsfDRRdFEScjS08yrFdZp86XRKWads



TRICARE Formulary Change

National VFW - 5/12/2017

Nexium, a popular drug used to treat gastroesophageal reflux disease, will be removed from TRICARE's formulary list. Effective June 28, 2017, the drug will no longer be available in military hospitals and clinics and those patients who choose to remain on the drug will pay increased fees. The change comes because the drug's producer, biopharmaceutical company AstraZeneca, cancelled the Department of Defense's 10-year Nexium preferred pricing agreement on April 1. The increased price is costing the DOD an additional $1.6 million per day. The almost 338,000 TRICARE patients currently prescribed Nexium are advised to contact their doctors to determine if Nexium is medically necessary or if they can safely be switched to an alternative drug. Patients taking Nexium should receive letters from the Defense Health Agency with more details. Read more about alternatives and costs.

Post News

Important Info for Post1393 Members

VFW News and Publications

Newsletter coming soon!

Statewide News

News & Info from your department

Help us learn about Alzheimer's disease in Veterans - Volunteers are needed for a research study

Participants will receive $75 for regular study visits and up to $175 for biomarker visits.

Badger Football Ticket Lottery for Veterans Now Open

You Could Receive Two Free Tickets to a Badger Football Game

National News

Important info from National VFW

VFW Action Alert: Take Action Now

Congress is voting now on the National Defense Authorization Act (NDAA) for Fiscal Year 2022. There are two critical amendments that NEED to stay! ...

VFW Joins Other VSOs to Launch 9/11 Memorial Golf Fund

KANSAS CITY, Mo. - The Veterans of Foreign Wars has joined together with four other veterans service organizations to launch the 9...